MAXD is going SICK

Winning the Grocery Game One Store at a Time Here's the scoop—Island Pacific Seafood Market just rolled up the shutters on their 22nd supermarket at 4044 N. Eagle Rock Boulevard in the bustling hub of Glassell Park, Los Angeles. This ain't just some ho-hum store opening; it's a celebration rooted in Filipino heritage, smack in the middle of Northeast L.A., where culture...

IASO Bio’s done it—they've taken a leap into Singapore with their fully human BCMA-targeted CAR-T cell therapy, FUCASO. November 3 was the official launch day, a big moment in Southeast Asia’s healthcare hub. And we're not just talking any therapy. This is a world-first fully human BCMA CAR-T hitting Singapore's market after getting the nod from the Health Sciences...

Movie Magic on the Menu When was the last time a bucket of fried chicken sent such ripple effects through pop culture? KFC's decision to sling Doctor Doom-inspired dishes across 100 countries smells like genius business mixed with a dash of the absurd. Just imagine: an empire of battered birds aligning with Marvel's latest cinematic heavy hitter, "Avengers: Doomsday." Now...

Ambitious Plans Unveiled at Taiwan Weeks 2026 Forget the usual humdrum; Taiwan’s pulling no punches in its bid to become a capital powerhouse in Asia. If you'd told me years ago that Taiwan was eyeing dominance in asset management, I might've laughed. But at the 2026 Taiwan Weeks, they showed they're dead serious about it. Over 400 bigwigs and market shakers gathered,...

Financial Miss Spurs Investigation When you've been in this racket as long as I have, you learn that missing consensus earnings even by a few cents can stir up a financial hornet's nest. That's precisely where Neutron Holdings Inc., better known as Lime, finds itself. With their third-quarter earnings slipping two cents below expectation, at $0.63 against a $0.66 to $0.68...

Transforming Security Assessments with SensAI Security screenings are about to get a serious upgrade with SensAI Veritas rolling out their latest toys—the SensAI Gateway™ and Helm™. Forget what you knew about traditional identity checks; this is all about diving deeper to sniff out those hidden risks before anyone gets a green light. From Static Checks to Dynamic...

Digging Deep at Trapper North: Saga's Strategic Drill Move There's nothing like the thrill of discovery, especially in the rough-and-tumble world of mining exploration. Saga Metals Corp., anchored deep in the critical minerals scene, has wrapped up an HQ-diameter drill program at its Radar Project, smack dab near Cartwright, Labrador. You hear 1,010 meters and maybe...

Rattling the Silicon Cage: GaNrich's Transformative Climb Well, folks, here's a story that makes even the most stoic traders sit up and take notice: GaNrich Semiconductor, a Taiwan-based trailblazer, is serving a wallop to the traditional silicon power device monopoly. By expanding their GaN power device portfolio to cover voltages ranging a whopping 40V to 1200V, GaNrich...

A Breakthrough for Ecobat Workers Man, when it comes to contracts, this recent deal at Ecobat is as game-changing as they get. A vote just ripped through like a hurricane, with 220 workers under Teamsters Local 986 eagerly ratifying a new three-year agreement that signals more than just a better payday. We're talking the largest wage boost these folks have clapped eyes on...

There's a new player shaking up the space game, and it's called the Physics Twin. Flexcompute, a trailblazer in AI-driven physics modeling, just rolled this out to help figure out how thruster plumes mess with nearby spacecraft. Trust me, this ain't your garden-variety simulation tool. Why Thruster Plumes Matter If you're in the business of dancing spacecraft around each...

Citi Confirms Positive Outlook for Alnylam Pharmaceuticals Citi has reaffirmed its Buy rating and a price target of $342.00 for Alnylam Pharmaceuticals (NASDAQ: ALNY). This supportive action follows Alnylam's recent TTR Investor Day presentation, which underscored the challenges and treatment needs related to transthyretin amyloid cardiomyopathy (ATTR-CM). The event...

Updates on Orchid Island Capital's Monthly Dividend Orchid Island Capital, Inc. (NYSE: ORC) has officially declared a monthly cash dividend of $0.12 per share for May 2025, providing a continued commitment to shareholder returns. This dividend is slated for distribution to stockholders on June 27, 2025, ensuring that investors remain rewarded for their confidence in the...

Preparing for Rigel Pharmaceuticals' Quarterly Earnings Rigel Pharmaceuticals (NASDAQ:RIGL) is set to unveil its quarterly earnings soon. Investors may benefit from understanding key elements ahead of this important announcement. Expected Earnings Insights Analysts predict that Rigel Pharmaceuticals will report an earnings per share (EPS) of $0.85. This forecast reflects...

Biodesix, Inc. Presentation at Major Growth Event Biodesix, Inc. (NASDAQ: BDSX), a pioneer in diagnostic solutions, is gearing up to present at the Canaccord Genuity 45th Annual Growth Conference. The event will showcase insights into the company's innovative approaches to enhancing clinical care and patient outcomes. Key Details of the Conference Engagement Scheduled for...

Three Collective Unveils Adaptive Apartment Community Welcome to the future of urban living! Three Collective, often referred to as 3co, represents a remarkable transformation of underutilized office towers into a modern and vibrant apartment community featuring 675 apartments and a wealth of amenities. Reimagining Office Spaces into Homes Driven by The Wolff Company's...